These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 20884658

  • 1. Changes in health-related quality of life with smoking cessation treatment.
    Hays JT, Croghan IT, Baker CL, Cappelleri JC, Bushmakin AG.
    Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
    Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, Hurt RD.
    JAMA; 2014 Jan 08; 311(2):155-63. PubMed ID: 24399554
    [Abstract] [Full Text] [Related]

  • 4. Varenicline and bupropion sustained-release combination therapy for smoking cessation.
    Ebbert JO, Croghan IT, Sood A, Schroeder DR, Hays JT, Hurt RD.
    Nicotine Tob Res; 2009 Mar 08; 11(3):234-9. PubMed ID: 19246427
    [Abstract] [Full Text] [Related]

  • 5. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR, Varenicline Phase 3 Study Group.
    JAMA; 2006 Jul 05; 296(1):47-55. PubMed ID: 16820546
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR, Varenicline Phase 3 Study Group.
    JAMA; 2006 Jul 05; 296(1):56-63. PubMed ID: 16820547
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K.
    Arch Intern Med; 2006 Jul 05; 166(15):1571-7. PubMed ID: 16908789
    [Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K, Jormanainen V, Linna M, Sintonen H, Wilson K, Kotomäki T.
    Curr Med Res Opin; 2010 Mar 05; 26(3):549-60. PubMed ID: 20050814
    [Abstract] [Full Text] [Related]

  • 9. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D, Tappenden P, Peters J, Kenjegalieva K.
    Health Technol Assess; 2009 Sep 05; 13 Suppl 2():9-13. PubMed ID: 19804684
    [Abstract] [Full Text] [Related]

  • 10. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA, Fiedler-Kelly J, Glover ED, Sachs DP, Grasela TH, DeVeaugh-Geiss J.
    Nicotine Tob Res; 2001 May 05; 3(2):131-40. PubMed ID: 11403727
    [Abstract] [Full Text] [Related]

  • 11. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD, Dugan SE.
    Clin Ther; 2009 Mar 05; 31(3):463-91. PubMed ID: 19393839
    [Abstract] [Full Text] [Related]

  • 12. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E, Ball MP, Buchholz AS, Gold JM, Evins AE, McMahon RP, Buchanan RW.
    J Clin Psychiatry; 2012 Jan 05; 73(1):95-102. PubMed ID: 21535998
    [Abstract] [Full Text] [Related]

  • 13. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.
    J Clin Psychopharmacol; 2007 Aug 05; 27(4):380-6. PubMed ID: 17632223
    [Abstract] [Full Text] [Related]

  • 14. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
    Cinciripini PM, Robinson JD, Karam-Hage M, Minnix JA, Lam C, Versace F, Brown VL, Engelmann JM, Wetter DW.
    JAMA Psychiatry; 2013 May 05; 70(5):522-33. PubMed ID: 23536105
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Fiore MC, Baker TB.
    Nicotine Tob Res; 2008 Apr 05; 10(4):717-29. PubMed ID: 18418793
    [Abstract] [Full Text] [Related]

  • 16. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
    Rose JE, Behm FM.
    Am J Psychiatry; 2014 Nov 01; 171(11):1199-205. PubMed ID: 24934962
    [Abstract] [Full Text] [Related]

  • 17. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence.
    Hays JT, Leischow SJ, Lawrence D, Lee TC.
    Nicotine Tob Res; 2010 Jun 01; 12(6):574-81. PubMed ID: 20457644
    [Abstract] [Full Text] [Related]

  • 18. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C, Xiao D, Chan KP, Pothirat C, Garza D, Davies S.
    Respirology; 2009 Apr 01; 14(3):384-92. PubMed ID: 19192221
    [Abstract] [Full Text] [Related]

  • 19. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
    Wong J, Abrishami A, Yang Y, Zaki A, Friedman Z, Selby P, Chapman KR, Chung F.
    Anesthesiology; 2012 Oct 01; 117(4):755-64. PubMed ID: 22890119
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ, Hansen NC, Søes-Petersen U, Evald T, Høegholm A, Barber J, Vestbo J.
    Nicotine Tob Res; 2004 Feb 01; 6(1):55-61. PubMed ID: 14982688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.